// App-Quantinova.ai

SYM04 : Post Hoc Analysis of Nabiximols Efficacy By Concomitant Medication Use in 2 Enriched Placebo-Controlled Randomized Clinical Trials (RCTs)

Researchers

Presenter

  • Faria Amjad

Principal Investigators

  • Aaron L Boster

  • Javier Carod Artal

  • Robert Chinnapongse

  • Daniel Checketts

  • Peyman Adjamian

  • Joshua R. Steinerman

Medical Centers

  • Georgetown University, Washington, DC

  • The Boster Center for Multiple Sclerosis, Columbus, OH

  • Raigmore Hospital, NHS Highlands, Scotland, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Nutritional risk screening

Drug/Treatment

  • Tetrahydrocannabinol

  • Cannabidiol

  • Baclofen

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved